| Symbol |
Name |
|
ABI2
|
abl-interactor 2
|
|
ACTG1
|
actin gamma 1
|
|
ACVR1B
|
activin A receptor, type IB
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKTIP
|
AKT interacting protein
|
|
AMBRA1
|
autophagy/beclin-1 regulator 1
|
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
ARIH1
|
ariadne RBR E3 ubiquitin protein ligase 1
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASB4
|
ankyrin repeat and SOCS box containing 4
|
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
|
|
ATXN3
|
ataxin 3
|
|
ATXN3L
|
ataxin 3-like
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
BAG5
|
BCL2-associated athanogene 5
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BID
|
BH3 interacting domain death agonist
|
|
BLZF1
|
basic leucine zipper nuclear factor 1
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CACUL1
|
CDK2-associated, cullin domain 1
|
|
CALR
|
calreticulin
|
|
CASC3
|
cancer susceptibility candidate 3
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta)
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CDC34
|
cell division cycle 34
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CLU
|
clusterin
|
|
CUL1
|
cullin 1
|
|
CUL2
|
cullin 2
|
|
CUL3
|
cullin 3
|
|
CUL4A
|
cullin 4A
|
|
CUL4B
|
cullin 4B
|
|
CUL5
|
cullin 5
|
|
CUL7
|
cullin 7
|
|
CUL9
|
cullin 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DAXX
|
death-domain associated protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DLG3
|
discs, large homolog 3 (Drosophila)
|
|
DNAJA1
|
DnaJ (Hsp40) homolog, subfamily A, member 1
|
|
DNM1L
|
dynamin 1-like
|
|
DTX1
|
deltex 1, E3 ubiquitin ligase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR2
|
early growth response 2
|
|
EIF4E2
|
eukaryotic translation initiation factor 4E family member 2
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAF2
|
Fas associated factor family member 2
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FHIT
|
fragile histidine triad
|
|
FOXO1
|
forkhead box O1
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD5
|
frizzled class receptor 5
|
|
FZD6
|
frizzled class receptor 6
|
|
FZD8
|
frizzled class receptor 8
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC6
|
histone deacetylase 6
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HM13
|
histocompatibility (minor) 13
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
JKAMP
|
JNK1/MAPK8-associated membrane protein
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MFN2
|
mitofusin 2
|
|
MID1
|
midline 1
|
|
MOAP1
|
modulator of apoptosis 1
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAE1
|
NEDD8 activating enzyme E1 subunit 1
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NKD2
|
naked cuticle homolog 2 (Drosophila)
|
|
NLK
|
nemo-like kinase
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PACRG
|
PARK2 co-regulated
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX6
|
paired box 6
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PER1
|
period circadian clock 1
|
|
PER3
|
period circadian clock 3
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRR5L
|
proline rich 5 like
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RB1
|
retinoblastoma 1
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNF20
|
ring finger protein 20, E3 ubiquitin protein ligase
|
|
RNF31
|
ring finger protein 31
|
|
RNF34
|
ring finger protein 34, E3 ubiquitin protein ligase
|
|
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RPA2
|
replication protein A2, 32kDa
|
|
SCAMP3
|
secretory carrier membrane protein 3
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SKI
|
SKI proto-oncogene
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SNX9
|
sorting nexin 9
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPOP
|
speckle-type POZ protein
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX8
|
syntaxin 8
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TCEB2
|
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
|
|
TCP1
|
t-complex 1
|
|
TF
|
transferrin
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMEM173
|
transmembrane protein 173
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TOLLIP
|
toll interacting protein
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIB1
|
tribbles pseudokinase 1
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIOBP
|
TRIO and F-actin binding protein
|
|
TSG101
|
tumor susceptibility 101
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
TUBB
|
tubulin, beta class I
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UBE2A
|
ubiquitin-conjugating enzyme E2A
|
|
UBE2B
|
ubiquitin-conjugating enzyme E2B
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE2F
|
ubiquitin-conjugating enzyme E2F (putative)
|
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1
|
|
UBE2G2
|
ubiquitin-conjugating enzyme E2G 2
|
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE2J1
|
ubiquitin-conjugating enzyme E2, J1
|
|
UBE2J2
|
ubiquitin-conjugating enzyme E2, J2
|
|
UBE2K
|
ubiquitin-conjugating enzyme E2K
|
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3
|
|
UBE2M
|
ubiquitin-conjugating enzyme E2M
|
|
UBE2N
|
ubiquitin-conjugating enzyme E2N
|
|
UBE2NL
|
ubiquitin-conjugating enzyme E2N-like (gene/pseudogene)
|
|
UBE2O
|
ubiquitin-conjugating enzyme E2O
|
|
UBE2R2
|
ubiquitin-conjugating enzyme E2R 2
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
|
UBE2T
|
ubiquitin-conjugating enzyme E2T
|
|
UBE2U
|
ubiquitin-conjugating enzyme E2U (putative)
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UBE2W
|
ubiquitin-conjugating enzyme E2W (putative)
|
|
UBE2Z
|
ubiquitin-conjugating enzyme E2Z
|
|
UBOX5
|
U-box domain containing 5
|
|
UBXN1
|
UBX domain protein 1
|
|
UBXN7
|
UBX domain protein 7
|
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3)
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
WASH1
|
WAS protein family homolog 1
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
ZNF675
|
zinc finger protein 675
|
|
ZNF746
|
zinc finger protein 746
|